Determining the correct drug regimen is absolutely essential for seeing optimal benefits. Initially, patients typically commence with a modest amount of around 2.4 mg, administered every week via subcutaneous . This initial amount is then gradually raised every four weeks , up to a peak dose of 10.8 mg, depending on patient effect and tolerance .